Tag: Drug Approvals
FDA Approves Novel Leg Prosthesis for AKAs
New device adheres to the leg with fixtures and screws implanted into the remaining thigh bone
FDA Approves Rexulti for Schizophrenia, Depression
But shouldn't be prescribed to some older people
![Iressa (gefitinib) has been approved by the U.S. Food and Drug Administration to treat patients with metastatic non-small-cell lung cancer with a specific genetic mutation (epidermal growth factor receptor [EGFR]). A just-approved companion diagnostic test can identify patients who could benefit from this new use.](https://www.ehealth-news.com/wp-content/uploads/2016/01/fdalogo-6-180x84.jpg "FDA Approves Iressa for EGFR+ Metastatic Lung Cancer")
FDA Approves Iressa for EGFR+ Metastatic Lung Cancer
New companion diagnostic kit can identify candidates
FDA Approves Entresto for Heart Failure
Medication helps reduce the rate of cardiovascular death, hospitalization
FDA Approves New Antiplatelet Drug for Patients Undergoing PCI
Kengreal prevents blood platelets from accumulating during percutaneous coronary intervention
FDA: Improved Artificial Heart Valve Approved
Changes designed to minimize leaks
FDA: Brain Stimulation Device Approved for Parkinson’s
For use in Parkinson's disease and essential tremor after medication alone proves inadequate
FDA Approves Rapamune for Lymphangioleiomyomatosis
Rare, progressive lung disease affects mostly women of child-bearing age
FDA: Two Drugs Approved for Irritable Bowel Syndrome
U.S. Food and Drug Administration approves Viberzi (eluxadoline) and Xifaxan (rifaximin)
FDA Approves Avelox for Treatment of Plague
Yersinia pestis bacterium could be released intentionally in bioterrorism
